Overview
Lobbying Costs
37,500€
Financial year: Dec 2013 - Dec 2014
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Norgine B.V.
EU Transparency Register
117307619414-45 First registered on 09 Nov 2015
Goals / Remit
Norgine B.V. is a European specialist pharma company which develops, manufactures and commercialises specialist products in the EU.
Main EU files targeted
File 2012/0266 on Medical Devices
Address
Head Office
Hogehilweg 7
Amsterdam Zuid-Oost 1101 CA
NETHERLANDSEU Office
Norgine NV/SA
Haasrode Research Park
Heverlee 3001
BELGIUM -
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Mr Peter Martin (COO)
Person with legal responsibility
Mr Peter Stein (CEO)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
http://www.eucope.org/en/
www.efpia.eu
European Medicines GroupMember organisations
http://www.eucope.org/en/
www.efpia.eu
European Medicines Group -
Financial Data
Closed financial year
Dec 2013 - Dec 2014
Lobbying costs for closed financial year
37,500€
Other financial info
n/a
-
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
Norgine currently works with a hired consultancy Decideum Ltd to engage members of the European Parliament, Commission and Council on the subject of the medical device file (2012/0266). This largely consists of the arrangement of meetings with relevant policy-makers to discuss the fulfilment of the aims and objectives of the file, to provide useful technical and contextual information relating to industry practice and to suggest improvements to the file where this is both applicable and appropriate.
Norgine monitors the activities of all three European institutions in order to inform the activities described above.Other activities
n/a
Meetings
Meetings
None declared